Interleukin-17 inhibition in psoriatic arthritis
Boyd, T.; Kavanaugh, A.
Clinical and Experimental Rheumatology 33(5 Suppl 93: S119-S123
2015
ISSN/ISBN: 0392-856X PMID: 26471234 Document Number: 680416
Greater understanding of the underlying disease process has led to the development of targeted therapeutic agents and innovative strategies in the treatment of psoriatic arthritis (PsA). This report addresses novel medications targeting the T helper 17 cell pathway, specifically those inhibiting interleukin-17A and its receptor, and discusses their role as effective therapies in the management of PsA.
Document emailed within 1 workday
Related Documents
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942Cohen, M.R.; Reda, D.J.; Clegg, D.O. 1999: Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies Journal of Rheumatology 26(8): 1752-1756
Theiss, B. 1971: Are there typical skin manifestations in psoriatic arthritis and psoriatic spondylarthritis? Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 22(2): 63-68
Salvarani, C.; Lo Scocco, G.; Macchioni, P.; Cremonesi, T.; Rossi, F.; Mantovani, W.; Battistel, B.; Bisighini, G.; Portioli, I. 1995: Prevalence of psoriatic arthritis in Italian psoriatic patients Journal of Rheumatology 22(8): 1499-1503
Patrizi, A.; Venturi, M.; Scorzoni, R.; Pazzaglia, M.; Malavolta, N.; Bardazzi, F. 2014: Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 177-184
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Korendowych, E.; Dixey, J.; Cox, B.; Jones, S.; McHugh, N. 2003: The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis Journal of Rheumatology 30(1): 96-101
Manara, M.; Caporali, R.; Favalli, E.G.; Grosso, V.; Atzeni, F.; Sarzi Puttini, P.; Gorla, R.; Bazzani, C.; Fusaro, E.; Pellerito, R.; Rocchetta, P.A.; Sinigaglia, L. 2017: Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry Clinical and Experimental Rheumatology 35(5): 804-809
Helliwell, P.S.; Wright, V. 1992: On the postulated co-existence of rheumatoid arthritis and psoriatic arthritis Clinical and Experimental Rheumatology 10(6): 625
Zbojanová, M.; Trnavský, K.; Schultz, P.; Vlcek, F. 1981: The spinal column in psoriatic arthritis and in psoriasis without arthritis Bratislavske Lekarske Listy 75(5): 567-576
Arman, A.; Yilmaz, B.; Coker, A.; Inanc, N.; Direskeneli, H. 2006: Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis Clinical and Experimental Rheumatology 24(6): 643-648
Rozenbaum, M.; Scharf, Y.; Katz, R.; Pollack, S. 1989: Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells of patients with rheumatoid arthritis Israel Journal of Medical Sciences 25(7): 372-376
Mihaela Spîrchez; Sama, G.şca; Ianc, M.; Bolba, C.; Miu, N. 2012: Relation of Interleukin-6, TNF-Alpha and Interleukin-1α with Disease Activity and Severity in Juvenile Idiopathic Arthritis Patients Clinical Laboratory 58(3-4): 253-260
Warrington, R.J. 1988: Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. a role for overproduction of interleukin-2 in human autoimmunity? Journal of Rheumatology 15(4): 616-620
Zhang, N.; Cui, H.-d.; Xue, H.-x. 2008: Effect of local viral transfer of interleukin 10 gene on a rabbit arthritis model induced by interleukin 1beta Chinese Medical Journal 121(5): 435-438
Tur Kaspa, R.; Ehrenfeld, M.; Eliakim, M. 1979: Psoriatic arthritis Harefuah 96(12): 668-670
Sills, E.M. 1980: Psoriatic arthritis in childhood Johns Hopkins Medical Journal 146(2): 49-53
Piaszek, L.; Stauch, G.W.; Hett, M.E. 1973: Psoriatic osteopathy without arthritis Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 119(6): 764-766
Karvonen, J.; Lassus, A.; Sievers, U.; Tiilikainen, A. 1974: HL-A antigens in psoriatic arthritis Annals of Clinical Research 6(5): 304-307
Schett, G. 2015: Apremilast in psoriatic arthritis Clinical and Experimental Rheumatology 33(5 Suppl 93: S98-100